Rheohaemapheresis in the treatment of nonvascular age-related macular degeneration

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00179906%3A_____%2F13%3A10133889" target="_blank" >RIV/00179906:_____/13:10133889 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00216208:11150/13:10133889

Výsledek na webu

<a href="http://dx.doi.org/10.1016/j.atherosclerosissup.2012.10.023" target="_blank" >http://dx.doi.org/10.1016/j.atherosclerosissup.2012.10.023</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1016/j.atherosclerosissup.2012.10.023" target="_blank" >10.1016/j.atherosclerosissup.2012.10.023</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Rheohaemapheresis in the treatment of nonvascular age-related macular degeneration

Popis výsledku v původním jazyce

Purpose: To evaluate the experience with rheohaemapheresis (RH) in the treatment of age-related macular degeneration (AMD). Methods: Thirty-eight patients were each treated with 8 procedures of RH (14 males, 24 females). The control group consisted of 34random patients (30 females, 4 males) with the dry form of AMD but not treated by RH. Our modification of the cascade method (named rheohaemapheresis) was used for plasma separation. After plasma separation (blood cell separator, Cobe Spectra, Denver, CO, USA), the separated plasma was pumped through a rheofilter (Evaflux 4A, Kuraray, Osaka, Japan) to remove lipoproteins and other high-molecular-weight rheologic factors. Results: In treated patients, best-corrected visual acuity (BCVA) increased significantly from 0.61 (0.06-1.00) to 0.68 (0.35-1.00) after 2.5 years (p = 0.035). We found no significant changes or differences in scotopic activity, whereas cone response and paramacular activity in the more peripheral region between 14 de

Název v anglickém jazyce

Rheohaemapheresis in the treatment of nonvascular age-related macular degeneration

Popis výsledku anglicky

Purpose: To evaluate the experience with rheohaemapheresis (RH) in the treatment of age-related macular degeneration (AMD). Methods: Thirty-eight patients were each treated with 8 procedures of RH (14 males, 24 females). The control group consisted of 34random patients (30 females, 4 males) with the dry form of AMD but not treated by RH. Our modification of the cascade method (named rheohaemapheresis) was used for plasma separation. After plasma separation (blood cell separator, Cobe Spectra, Denver, CO, USA), the separated plasma was pumped through a rheofilter (Evaflux 4A, Kuraray, Osaka, Japan) to remove lipoproteins and other high-molecular-weight rheologic factors. Results: In treated patients, best-corrected visual acuity (BCVA) increased significantly from 0.61 (0.06-1.00) to 0.68 (0.35-1.00) after 2.5 years (p = 0.035). We found no significant changes or differences in scotopic activity, whereas cone response and paramacular activity in the more peripheral region between 14 de

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FD - Onkologie a hematologie

OECD FORD obor

—

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2013

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Atherosclerosis Supplements

ISSN

1567-5688

e-ISSN

—

Svazek periodika

14

Číslo periodika v rámci svazku

1

Stát vydavatele periodika

IE - Irsko

Počet stran výsledku

6

Strana od-do

179-184

Kód UT WoS článku

000314885000030

EID výsledku v databázi Scopus

—